Home / ADAG : NASDAQ

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does ADAG make money? Does ADAG have pricing power? What's the Earnings Whisper? Will ADAG profit more as the business scales? What is ADAG's management track record? Is ADAG's current price justified?

Adagene Inc.

$3.4 +$1.56 (+84.78%)

NASDAQ · 11 Sep 2026 20:00 UTC

Previous Close

$3.31

Day Range

$3.24$3.48

Year Range

$1.3$4.85

Market Cap

128.01M

AVG Volume

230.5K

Trailing/Forward PE

-7.21/-

PEG ratio

-0.2

Dividend Yield

Next Earnings Date

2027-03-31

Primary Exchange

NASDAQ

Revenue (USD) · TTM

ADAG Revenue (USD) · TTM by quarter
Period	Revenue (USD) · TTM
24 Q2	815.75K
24 Q1	9.46M
23 Q4	18.11M
23 Q3	20.39M
23 Q2	22.67M
23 Q1	17.94M
22 Q4	11.25M
22 Q3	17.36M
22 Q2	19.08M
22 Q1	16.52M

Net Income (USD) · TTM

ADAG Net Income (USD) · TTM by quarter
Period	Net Income (USD) · TTM
24 Q2	-31.85M
24 Q1	-25.4M
23 Q4	-18.95M
23 Q3	-27.69M
23 Q2	-36.44M
23 Q1	-82.03M
22 Q4	-103.79M
22 Q3	-123.51M
22 Q2	-125.34M
22 Q1	-114.89M

Operating Income (USD) · TTM

ADAG Operating Income (USD) · TTM by quarter
Period	Operating Income (USD) · TTM
24 Q2	-36.99M
24 Q1	-30.36M
23 Q4	-23.72M
23 Q3	-32.31M
23 Q2	-40.9M
23 Q1	-86.45M
22 Q4	-107.96M
22 Q3	-124.8M
22 Q2	-124.3M
22 Q1	-113.73M

EBITDA (USD) · TTM

ADAG EBITDA (USD) · TTM by quarter
Period	EBITDA (USD) · TTM
24 Q2	-36.06M
24 Q1	-29.37M
23 Q4	-22.67M
23 Q3	-31.22M
23 Q2	-39.81M
23 Q1	-61.3M
22 Q4	-82.79M
22 Q3	-82.3M
22 Q2	-81.88M
22 Q1	-76.66M

Cash Flows (USD) · TTM

ADAG Cash Flows (USD) · TTM by quarter
Period	Cash Flows (USD) · TTM
24 Q2	-28.47M
24 Q1	-28.5M
23 Q4	-28.54M
23 Q3	2.23M
23 Q2	4.63M
23 Q1	14.22M
22 Q4	20.95M
22 Q3	20.95M
22 Q2	18.55M
22 Q1	15.69M

EPS (USD) · TTM

ADAG EPS (USD) · TTM by quarter
Period	EPS (USD) · TTM
24 Q2	-0.9
24 Q1	-0.72
23 Q4	-0.54
23 Q3	-0.8
23 Q2	-1.06
23 Q1	-2.36
22 Q4	-2.99
22 Q3	-3.54
22 Q2	-3.58
22 Q1	-3.49

Expenses (USD) · TTM

ADAG Expenses (USD) · TTM by quarter
Period	Expenses (USD) · TTM
24 Q2	37.9M
24 Q1	41.63M
23 Q4	45.36M
23 Q3	55.41M
23 Q2	66.25M
23 Q1	105.36M
22 Q4	118.46M
22 Q3	141.39M
22 Q2	142.6M
22 Q1	129.47M

Shares Outstanding · TTM

ADAG Shares Outstanding · TTM by quarter
Period	Shares Outstanding · TTM
24 Q2	-7.27M
24 Q1	-6.5M
23 Q4	-5.72M
23 Q3	-6.5M
23 Q2	-7.27M
23 Q1	-8.9M
22 Q4	-10.52M
22 Q3	-12.39M
22 Q2	-14.25M
22 Q1	-16.47M

Employee Count

ADAG Employee Count by quarter
Period	Employee Count
2025	128
2024	138
2023	174
2022	248
2021	259
2020	198

Free Cash Flow Yield

ADAG Free Cash Flow Yield by quarter
Period	Free Cash Flow Yield
Sep 26	-34.85%
Sep 26	-33.1%
Aug 26	-32.2%
Aug 26	-29.47%
Aug 26	-32.02%
Aug 26	-29.17%
Jul 26	-31.97%
Jul 26	-37.47%
Jul 26	-33.4%
Jul 26	-30.43%
Jul 26	-26.82%
Jun 26	-28.62%
Jun 26	-30.43%
Jun 26	-33.59%
Jun 26	-36.12%
May 26	-30.2%
May 26	-31.97%
May 26	-34.26%
May 26	-32.49%
May 26	-31.39%
Apr 26	-32.49%
Apr 26	-30.2%
Apr 26	-31.55%
Apr 26	-30.05%
Mar 26	-33.49%
Mar 26	-34.78%
Mar 26	-30.57%
Mar 26	-44.46%
Feb 26	-42.65%
Feb 26	-40.21%
Feb 26	-38.85%
Feb 26	-48.01%
Jan 26	-45.91%
Jan 26	-50.71%
Jan 26	-64.42%
Jan 26	-82.52%
Jan 26	-68.62%
Dec 25	-70.93%
Dec 25	-69.37%
Dec 25	-72.15%
Dec 25	-63.45%
Nov 25	-62.81%
Nov 25	-70.14%
Nov 25	-68.99%
Nov 25	-89.54%
Oct 25	-70.93%
Oct 25	-70.53%
Oct 25	-71.74%
Oct 25	-64.75%
Oct 25	-63.77%
Sep 25	-64.42%
Sep 25	-61.59%
Sep 25	-56.36%
Sep 25	-57.39%
Aug 25	-59.28%
Aug 25	-52.83%
Aug 25	-74.71%
Aug 25	-64.66%
Aug 25	-73.08%
Jul 25	-70.51%
Jul 25	-80.17%
Jul 25	-73.46%
Jul 25	-75.84%
Jun 25	-73.08%
Jun 25	-73.85%
Jun 25	-71.95%
Jun 25	-70.51%
May 25	-72.32%
May 25	-77.09%
May 25	-79.27%
May 25	-87.69%
May 25	-91.7%
Apr 25	-98.81%
Apr 25	-91.7%
Apr 25	-91.7%
Apr 25	-88.8%
Mar 25	-89.94%
Mar 25	-47.96%
Mar 25	-45.79%
Mar 25	-39.93%
Feb 25	-40.33%
Feb 25	-39.35%
Feb 25	-46.05%
Feb 25	-47.13%
Jan 25	-42.66%
Jan 25	-42%
Jan 25	-44.05%
Jan 25	-41.78%
Jan 25	-40.13%
Dec 24	-41.36%
Dec 24	-39.54%
Dec 24	-39.35%
Dec 24	-39.35%
Nov 24	-34.64%
Nov 24	-37.01%
Nov 24	-37.53%
Nov 24	-30.7%
Nov 24	-27.05%
Oct 24	-26.96%
Oct 24	-31.1%

Price to Sales

ADAG Price to Sales by quarter
Period	Price to Sales
Sep 26	16.35
Sep 26	17.22
Aug 26	17.7
Aug 26	19.33
Aug 26	17.79
Aug 26	19.98
Jul 26	18.23
Jul 26	15.56
Jul 26	17.46
Jul 26	19.16
Jul 26	21.74
Jun 26	20.37
Jun 26	19.16
Jun 26	17.36
Jun 26	16.14
May 26	19.3
May 26	18.23
May 26	17.02
May 26	17.94
May 26	18.57
Apr 26	17.94
Apr 26	19.3
Apr 26	18.48
Apr 26	19.4
Mar 26	1376.83
Mar 26	1325.7
Mar 26	1508.3
Mar 26	1037.19
Feb 26	1081.01
Feb 26	1146.75
Feb 26	1186.92
Feb 26	960.49
Jan 26	1004.32
Jan 26	909.36
Jan 26	715.81
Jan 26	558.77
Jan 26	671.98
Dec 25	650.07
Dec 25	664.68
Dec 25	639.11
Dec 25	726.76
Nov 25	734.07
Nov 25	657.37
Nov 25	668.33
Nov 25	514.94
Oct 25	650.07
Oct 25	653.72
Oct 25	642.76
Oct 25	712.15
Oct 25	723.11
Sep 25	715.81
Sep 25	748.67
Sep 25	818.06
Sep 25	803.45
Aug 25	777.89
Aug 25	872.84
Aug 25	617.2
Aug 25	155.88
Aug 25	137.92
Jul 25	142.95
Jul 25	125.71
Jul 25	137.2
Jul 25	132.89
Jun 25	137.92
Jun 25	136.48
Jun 25	140.07
Jun 25	142.95
May 25	139.36
May 25	130.74
May 25	127.14
May 25	114.93
May 25	109.9
Apr 25	102
Apr 25	109.9
Apr 25	109.9
Apr 25	113.5
Mar 25	112.06
Mar 25	72.76
Mar 25	76.21
Mar 25	87.4
Feb 25	86.54
Feb 25	88.69
Feb 25	75.77
Feb 25	74.05
Jan 25	81.8
Jan 25	83.09
Jan 25	79.22
Jan 25	83.52
Jan 25	86.97
Dec 24	84.39
Dec 24	88.26
Dec 24	88.69
Dec 24	88.69
Nov 24	100.75
Nov 24	94.29
Nov 24	93
Nov 24	113.66
Nov 24	11.13
Oct 24	11.17
Oct 24	9.69

Price/Operating Cashflow

ADAG Price/Operating Cashflow by quarter
Period	Price/Operating Cashflow
Mar 24	66.58
Mar 24	59.92
Mar 24	67.77
Mar 24	67.05
Mar 24	77.99
Feb 24	77.75
Feb 24	72.29
Feb 24	87.5
Feb 24	82.75
Jan 24	93.92
Jan 24	62.77
Jan 24	75.38
Jan 24	50.41
Dec 23	45.89
Dec 23	39.95
Dec 23	36.38
Dec 23	44.7
Dec 23	36.14
Nov 23	12.22
Nov 23	11.62
Nov 23	12.22
Nov 23	11.45
Oct 23	11.54
Oct 23	11.88
Oct 23	11.96
Oct 23	14.13
Sep 23	12.98
Sep 23	10.95
Sep 23	11.96
Sep 23	12.3
Sep 23	11.71
Aug 23	2.94
Aug 23	2.81
Aug 23	3.27
Aug 23	3.3
Jul 23	3.35
Jul 23	3.35
Jul 23	3.57
Jul 23	3.91
Jun 23	3.62
Jun 23	3.3
Jun 23	3.13
Jun 23	3.05
Jun 23	3.25
May 23	2.38
May 23	2.51
May 23	2.36
May 23	2.26
Apr 23	2.21
Apr 23	2.38
Apr 23	2.51
Apr 23	2.5
Mar 23	2.45
Mar 23	2.53
Mar 23	2.68
Mar 23	2.28
Mar 23	2.85
Feb 23	2.94
Feb 23	3.14
Feb 23	3.16
Feb 23	3.17
Jan 23	3.29
Jan 23	2.84
Jan 23	3
Jan 23	2.7
Dec 22	2.24
Dec 22	2.13
Dec 22	2.46
Dec 22	2.28
Dec 22	1.92
Nov 22	1.96
Nov 22	2.04
Nov 22	1.96
Nov 22	1.9
Oct 22	1.89
Oct 22	2.36
Oct 22	2.57
Oct 22	2.67
Sep 22	2.51
Sep 22	2.66
Sep 22	2.75
Sep 22	3.1
Sep 22	2.99
Aug 22	3.3
Aug 22	3.02
Aug 22	3.3
Aug 22	3.44
Jul 22	3.96
Jul 22	4.29
Jul 22	4.53
Jul 22	4.89
Jul 22	4.66
Jun 22	4.68
Jun 22	4.68
Jun 22	5.99
Jun 22	6.56
May 22	6.56
May 22	6.61
May 22	7.48
May 22	7.57

Price to Book

ADAG Price to Book by quarter
Period	Price to Book
Sep 26	1.45
Sep 26	1.53
Aug 26	1.57
Aug 26	1.72
Aug 26	1.58
Aug 26	4.41
Jul 26	4.02
Jul 26	3.43
Jul 26	3.85
Jul 26	4.23
Jul 26	4.79
Jun 26	4.49
Jun 26	4.23
Jun 26	3.83
Jun 26	3.56
May 26	4.26
May 26	4.02
May 26	3.75
May 26	3.96
May 26	4.1
Apr 26	3.96
Apr 26	4.26
Apr 26	4.08
Apr 26	4.28
Mar 26	3.75
Mar 26	3.61
Mar 26	4.11
Mar 26	2.82
Feb 26	2.94
Feb 26	3.12
Feb 26	3.23
Feb 26	2.61
Jan 26	2.73
Jan 26	2.48
Jan 26	1.95
Jan 26	1.52
Jan 26	1.83
Dec 25	1.77
Dec 25	1.81
Dec 25	1.74
Dec 25	1.98
Nov 25	2
Nov 25	1.79
Nov 25	1.82
Nov 25	1.4
Oct 25	1.77
Oct 25	1.78
Oct 25	1.75
Oct 25	1.94
Oct 25	1.97
Sep 25	1.95
Sep 25	2.04
Sep 25	2.23
Sep 25	2.19
Aug 25	2.12
Aug 25	2.38
Aug 25	1.68
Aug 25	1.58
Aug 25	1.4
Jul 25	1.45
Jul 25	1.27
Jul 25	1.39
Jul 25	1.34
Jun 25	1.4
Jun 25	1.38
Jun 25	1.42
Jun 25	1.45
May 25	1.41
May 25	1.32
May 25	1.29
May 25	1.16
May 25	1.11
Apr 25	1.03
Apr 25	1.11
Apr 25	1.11
Apr 25	1.15
Mar 25	1.13
Mar 25	1.05
Mar 25	1.1
Mar 25	1.26
Feb 25	1.25
Feb 25	1.28
Feb 25	1.09
Feb 25	1.07
Jan 25	1.18
Jan 25	1.2
Jan 25	1.14
Jan 25	1.2
Jan 25	1.25
Dec 24	1.22
Dec 24	1.27
Dec 24	1.28
Dec 24	1.28
Nov 24	1.45
Nov 24	1.36
Nov 24	1.34
Nov 24	1.64
Nov 24	1.86
Oct 24	1.87
Oct 24	1.62

No video analysis for this stock yet. Request one from our team.

News: ADAG

globenewswire.com · 10 Sep 2026

Adagene Announces that Third Arc Bio Has Selected First Lead Candidate under Amended Strategic Collaboration for Development of Masked CD3 T Cell Engagers Utilizing SAFEbody® Technology

Amended terms of agreement include a transition to an integrated asset and technology partnership. SAN DIEGO and SUZHOU, China, Sept.

globenewswire.com · 9 Sep 2026

Adagene Achieves Milestone in Collaboration with Exelixis for Advancement of SAFEbody® Antibody-Drug Conjugate Candidates

SAN DIEGO and SUZHOU, China, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a platform-driven, clinical-stage biotechnology company transforming the discovery and development of novel antibody-based therapies, today announced the achievement of a milestone in its ongoing collaboration and license agreement with Exelixis, Inc. (“Exelixis”).

globenewswire.com · 20 Aug 2026

Adagene to Participate in Three Upcoming Investor Conferences

SAN DIEGO and SUZHOU, China, Aug. 20, 2026 (GLOBE NEWSWIRE) -- Adagene Inc. (Nasdaq: ADAG) a platform-driven, clinical-stage biotechnology company transforming the discovery and development of novel antibody-based therapies, today announced that senior management will participate in three upcoming investor conferences taking place in New York, New York. 2026 Cantor Global Healthcare Conference; New York, NY – September 9-11, 2026 Format: 1x1 Meetings Date/Time: September 11, 2026 Morgan Stanley 24th Annual Global Healthcare Conference; New York, NY – September 14-16, 2026 Format: Fireside Chat and 1x1 Meetings Fireside Chat Date/Time: September 15, 2026, 10:45–11:20 AM (Eastern Time) H.C.

globenewswire.com · 12 Aug 2026

Adagene Reports Six Months 2026 Financial Results and Provides Corporate Updates

Randomized Phase 2 trial in microsatellite stable colorectal cancer (MSS CRC) ongoing, with results expected in 1H 2027; potential registration trial expected in 2027 once recommended dose regimen has been established